A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
